Clinical Trial Update: Evaluation of Efficacy and Safety of E004 in Children With Asthma [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluating the efficacy and safety of E004 in pediatric asthma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• E004

Snippet

Sponsor: Amphastar Pharmaceuticals, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED